Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

5.0K
Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
5.0K
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

389
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
389
Acute Kidney Injury V: Interprofessional Care01:20

Acute Kidney Injury V: Interprofessional Care

498
Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
498
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

727
Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
727
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

829
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
829
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

353
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
353

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Development of a neurologic deterioration risk score in pediatric mild traumatic brain injury and intracranial injuries.

The journal of trauma and acute care surgery·2026
Same author

Reevaluating the 1 Hour Benchmark: Associations Between Antibiotic Timing and Mortality in Pediatric Sepsis.

Clinical pediatrics·2025
Same author

Triage Temperature and Timeliness of Sepsis Interventions in a Pediatric Emergency Department.

The western journal of emergency medicine·2025
Same author

Emergency Department Sepsis Triage Scoring Tool Elements Associated With Hypotension Within 24 Hours in Children With Fever and Tachycardia.

Pediatric emergency care·2024
Same author

Can an unplanned extubation checklist solely identify children at-risk for adverse events? A response to the pediatric unplanned extubation risk score.

Heart & lung : the journal of critical care·2023
Same author

Intravenous Fluid Bolus Rates Associated with Outcomes in Pediatric Sepsis: A Multi-Center Analysis.

Open access emergency medicine : OAEM·2022

Related Experiment Video

Updated: Apr 13, 2026

A Controlled Mouse Model for Neonatal Polymicrobial Sepsis
14:54

A Controlled Mouse Model for Neonatal Polymicrobial Sepsis

Published on: January 27, 2019

12.0K

Quality improvement in pediatric sepsis.

Elliot Melendez1, Richard Bachur

  • 1aDivision of Medicine Critical Care bDivision of Emergency Medicine, Boston Children's Hospital, Boston, Massachusetts, USA.

Current Opinion in Pediatrics
|May 7, 2015
PubMed
Summary

Standardizing the definition of sepsis onset is crucial for improving pediatric sepsis care. Consistent definitions will enable better evaluation of quality improvement initiatives and ensure timely interventions for critically ill children.

More Related Videos

A Neonatal Imaging Model of Gram-Negative Bacterial Sepsis
08:46

A Neonatal Imaging Model of Gram-Negative Bacterial Sepsis

Published on: August 12, 2020

7.1K
Design of Cecal Ligation and Puncture and Intranasal Infection Dual Model of Sepsis-Induced Immunosuppression
07:30

Design of Cecal Ligation and Puncture and Intranasal Infection Dual Model of Sepsis-Induced Immunosuppression

Published on: June 15, 2019

10.7K

Related Experiment Videos

Last Updated: Apr 13, 2026

A Controlled Mouse Model for Neonatal Polymicrobial Sepsis
14:54

A Controlled Mouse Model for Neonatal Polymicrobial Sepsis

Published on: January 27, 2019

12.0K
A Neonatal Imaging Model of Gram-Negative Bacterial Sepsis
08:46

A Neonatal Imaging Model of Gram-Negative Bacterial Sepsis

Published on: August 12, 2020

7.1K
Design of Cecal Ligation and Puncture and Intranasal Infection Dual Model of Sepsis-Induced Immunosuppression
07:30

Design of Cecal Ligation and Puncture and Intranasal Infection Dual Model of Sepsis-Induced Immunosuppression

Published on: June 15, 2019

10.7K

Area of Science:

  • Pediatric critical care medicine
  • Quality improvement science
  • Infectious disease epidemiology

Background:

  • Literature on quality improvement in adult sepsis is extensive, but pediatric sepsis research is limited.
  • Key challenges in pediatric sepsis include defining the exact onset ('time zero') and identifying which patients require aggressive management.
  • Current definitions of sepsis onset, particularly in emergency departments, are not universally applicable to all pediatric patient populations.

Purpose of the Study:

  • To highlight the need for standardized definitions in pediatric sepsis quality improvement.
  • To address the lack of clarity regarding sepsis onset ('time zero') in pediatric patients.
  • To advocate for consistent evaluation metrics across different healthcare settings.

Main Methods:

  • Review of existing literature on pediatric sepsis and quality improvement.
  • Analysis of challenges in defining sepsis onset and patient stratification.
  • Discussion of the implications of variable definitions on research generalizability.

Main Results:

  • Despite varied definitions of 'time zero,' aggressive fluid administration, prompt antibiotics, and adherence to sepsis bundles improve outcomes.
  • Early identification tools show potential for defining sepsis onset.
  • Retrospective search tools can aid in identifying pediatric sepsis cases.

Conclusions:

  • Quality improvement efforts in pediatric sepsis are advancing but require standardized definitions.
  • A universally applicable definition of sepsis onset is needed for consistent evaluation across all treatment venues.
  • Further research should focus on defining patient populations for timely interventions and standardizing outcome measures beyond mortality.